Since 1986 - Covering the Fastest Computers in the World and the People Who Run Them

Language Flags
February 14, 2012

Biotech Firm Doubles Down on Amazon Cloud

Tiffany Trader

Life science companies are increasingly looking to the cloud as a way of facilitating more efficient business models. That was the case with Metrum Research Group, a Connecticut-based biotech firm that transferred its entire IT infrastructure onto the Amazon cloud.

biotech, cloudWhile many companies are comfortable taking cloud baby steps, Metrum made the big leap into the fluffy white stuff. According to an article in Bio-IT World, the company “is leveraging the capabilities of Amazon Web Services (AWS) for its core pharmacometrics technology platform, with Elastic Compute Cloud (EC2), Simple Storage Service (S3), and Elastic Block Storage (EBS) services. Highly secure VPC environments are under development and nearing deployment.”

Before the switch, Metrum, ran its modeling and simulation workloads on a traditional co-located computational grid system comprised of six servers and 32 cores. Due to uneven resource demand, it was common for the grid to be over- or under-subscribed, not the best use of resources. During busy times, 32 cores was not enough, Jeffrey Hane, CIO and COO of Metrum Research Group, tells BIO-IT World, and other times a portion of the cores sat idle.

As the company grew, it became clear that they needed to expand their computing infrastructure. “Unlimited, flexible compute power was the driving force to go to the cloud. We also wanted to simplify, and we didn’t want a hybrid system. So we opted to move everything up,” explains Hane.

The cloud deployment has been up and running for several months now and Hane outlines several benefits. Whereas the entire company previously shared 32 cores, now each scientist has access to at least 100 multicore instances launched on demand from their workstations. This increase in computational power has led to quicker turnaround times. In some cases, this means a return measured in hours instead of days. Hane explains that while the system is much easier to manage, costs are about the same as before. Plus he anticipates that increased customer satisfaction will result in a higher ROI.

As for potential drawbacks, the COO notes that despite having increased control over system compliance, he fully expects to be challenged under FDA compliance guidelines (21 CFR Part 11). Being able to identify improvements and employing security tools will assist the company in explaining their position.

SC14 Virtual Booth Tours

AMD SC14 video AMD Virtual Booth Tour @ SC14
Click to Play Video
Cray SC14 video Cray Virtual Booth Tour @ SC14
Click to Play Video
Datasite SC14 video DataSite and RedLine @ SC14
Click to Play Video
HP SC14 video HP Virtual Booth Tour @ SC14
Click to Play Video
IBM DCS3860 and Elastic Storage @ SC14 video IBM DCS3860 and Elastic Storage @ SC14
Click to Play Video
IBM Flash Storage
@ SC14 video IBM Flash Storage @ SC14  
Click to Play Video
IBM Platform @ SC14 video IBM Platform @ SC14
Click to Play Video
IBM Power Big Data SC14 video IBM Power Big Data @ SC14
Click to Play Video
Intel SC14 video Intel Virtual Booth Tour @ SC14
Click to Play Video
Lenovo SC14 video Lenovo Virtual Booth Tour @ SC14
Click to Play Video
Mellanox SC14 video Mellanox Virtual Booth Tour @ SC14
Click to Play Video
Panasas SC14 video Panasas Virtual Booth Tour @ SC14
Click to Play Video
Quanta SC14 video Quanta Virtual Booth Tour @ SC14
Click to Play Video
Seagate SC14 video Seagate Virtual Booth Tour @ SC14
Click to Play Video
Supermicro SC14 video Supermicro Virtual Booth Tour @ SC14
Click to Play Video